TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 1 | -1 | -2 | -7 | -21 | -25 | -9 |
| S | %wins | 25 | 75 | 75 | 75 | 75 | 100 | 71 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/26/14 16:01 | 2/24/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Rosman Nachum | L3 | D | S | -180 | 4.00 | 1 | -45 | -17 | 223 | I | 63 | 25 | 26 | 24 | -7 | 6 | 0 | 1 | 1 | 0 | -10 | -17 | -35 | -25 | |
2/12/14 16:08 | 2/10/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Rosman Nachum | L3 | D | S | -141 | 4.02 | 2 | -35 | -12 | 268 | I | 58 | 31 | 36 | 27 | 28 | -2 | 6 | 11 | -1 | -1 | -5 | -13 | -34 | -31 | |
11/12/13 16:42 | 11/8/13 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Rosman Nachum | L3 | D | S.m | -220 | 3.27 | 1 | -67 | -21 | 253 | I | 16 | 2 | 10 | 9 | -5 | -11 | 0 | -2 | 1 | 1 | -4 | 22 | 5 | -22 | |
8/14/12 15:40 | 8/10/12 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Rosman Nachum | L3 | D | S | -234 | 4.25 | 6 | -55 | -19 | 235 | I | 271 | 60 | 61 | 43 | 71 | 28 | 28 | 15 | 2 | -2 | 11 | -19 | -18 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |